166 related articles for article (PubMed ID: 27197189)
1. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.
Rao S; Cai KQ; Stadanlick JE; Greenberg-Kushnir N; Solanki-Patel N; Lee SY; Fahl SP; Testa JR; Wiest DL
Cancer Res; 2016 Jun; 76(11):3387-96. PubMed ID: 27197189
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.
Rao S; Lee SY; Gutierrez A; Perrigoue J; Thapa RJ; Tu Z; Jeffers JR; Rhodes M; Anderson S; Oravecz T; Hunger SP; Timakhov RA; Zhang R; Balachandran S; Zambetti GP; Testa JR; Look AT; Wiest DL
Blood; 2012 Nov; 120(18):3764-73. PubMed ID: 22976955
[TBL] [Abstract][Full Text] [Related]
3. T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.
Hagenbeek TJ; Spits H
Leukemia; 2008 Mar; 22(3):608-19. PubMed ID: 18046443
[TBL] [Abstract][Full Text] [Related]
4. Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma.
Bélanger SD; St-Pierre Y
Blood; 2005 Jun; 105(12):4800-6. PubMed ID: 15705798
[TBL] [Abstract][Full Text] [Related]
5. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
6. Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling.
Solanki NR; Stadanlick JE; Zhang Y; Duc AC; Lee SY; Lauritsen JP; Zhang Z; Wiest DL
J Immunol; 2016 Sep; 197(6):2280-9. PubMed ID: 27489283
[TBL] [Abstract][Full Text] [Related]
7. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint.
Fahl SP; Harris B; Coffey F; Wiest DL
J Immunol; 2015 Jan; 194(1):200-9. PubMed ID: 25416806
[TBL] [Abstract][Full Text] [Related]
8. Suppression of T-cell lymphomagenesis in mice requires PTEN phosphatase activity.
Newton RH; Lu Y; Papa A; Whitcher GH; Kang YJ; Yan C; Pandolfi PP; Turka LA
Blood; 2015 Jan; 125(5):852-5. PubMed ID: 25477498
[TBL] [Abstract][Full Text] [Related]
9. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
[TBL] [Abstract][Full Text] [Related]
10. Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs.
Zhang Y; Duc AC; Rao S; Sun XL; Bilbee AN; Rhodes M; Li Q; Kappes DJ; Rhodes J; Wiest DL
Dev Cell; 2013 Feb; 24(4):411-25. PubMed ID: 23449473
[TBL] [Abstract][Full Text] [Related]
11. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Ravi D; Beheshti A; Abermil N; Passero F; Sharma J; Coyle M; Kritharis A; Kandela I; Hlatky L; Sitkovsky MV; Mazar A; Gartenhaus RB; Evens AM
Cancer Res; 2016 Jun; 76(11):3319-31. PubMed ID: 26988986
[TBL] [Abstract][Full Text] [Related]
12. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis.
Zhang B; Chen H; Zhang L; Dakhova O; Zhang Y; Lewis MT; Creighton CJ; Ittmann MM; Xin L
Oncogene; 2014 Jun; 33(24):3099-108. PubMed ID: 23851498
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of Myb and Myc proteins in T cell lymphomagenesis.
Davies J; Badiani P; Weston K
Oncogene; 1999 Jun; 18(24):3643-7. PubMed ID: 10380886
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.
Liu X; Karnell JL; Yin B; Zhang R; Zhang J; Li P; Choi Y; Maltzman JS; Pear WS; Bassing CH; Turka LA
J Clin Invest; 2010 Jul; 120(7):2497-507. PubMed ID: 20516645
[TBL] [Abstract][Full Text] [Related]
15. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint.
Anderson SJ; Lauritsen JP; Hartman MG; Foushee AM; Lefebvre JM; Shinton SA; Gerhardt B; Hardy RR; Oravecz T; Wiest DL
Immunity; 2007 Jun; 26(6):759-72. PubMed ID: 17555992
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.
Contreras JR; Palanichamy JK; Tran TM; Fernando TR; Rodriguez-Malave NI; Goswami N; Arboleda VA; Casero D; Rao DS
Oncotarget; 2015 May; 6(13):11023-37. PubMed ID: 25906746
[TBL] [Abstract][Full Text] [Related]
17. Roles of AML1/RUNX1 in T-cell malignancy induced by loss of p53.
Shimizu K; Yamagata K; Kurokawa M; Mizutani S; Tsunematsu Y; Kitabayashi I
Cancer Sci; 2013 Aug; 104(8):1033-8. PubMed ID: 23679839
[TBL] [Abstract][Full Text] [Related]
18. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
Burger ML; Xue L; Sun Y; Kang C; Winoto A
Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
